Billede af showet The Clinical Chronicle

The Clinical Chronicle

Podcast af Vijay Nethala

engelsk

Nyheder & politik

Begrænset tilbud

2 måneder kun 19 kr.

Derefter 99 kr. / månedOpsig når som helst.

  • 20 lydbogstimer pr. måned
  • Podcasts kun på Podimo
  • Gratis podcasts
Kom i gang

Læs mere The Clinical Chronicle

The Clinical Chronicle Podcast delivers concise, evidence-based updates from the frontlines of medicine. Hosted by Dr. Vijay Nethala, each episode breaks down the latest clinical research and guidelines across specialties—making complex medical advances clear and actionable. Whether you’re a resident, practicing physician, or healthcare professional, tune in for insights that help you stay ahead in patient care, with a focus on practical impact and cutting-edge science.Stay informed. Stay inspired. Join Dr. Nethala as he explores the evolving landscape of medicine, one breakthrough at a time.

Alle episoder

5 episoder

episode Practice-Changing Clinical Updates 2026: Stroke Guidelines, Hyponatremia Correction, Lung Cancer Screening, and GLP-1 in Colon Cancer cover

Practice-Changing Clinical Updates 2026: Stroke Guidelines, Hyponatremia Correction, Lung Cancer Screening, and GLP-1 in Colon Cancer

Welcome to Season 2, Episode 1 of The Clinical Chronicle. This episode delivers major practice-changing updates in medicine for 2026, including the new AHA and ASA acute ischemic stroke guideline, evolving evidence on sodium correction in severe hyponatremia, and why current lung cancer screening criteria may be missing more than 60 percent of patients at diagnosis. We break down expanded eligibility for endovascular thrombectomy in larger core strokes, the shift toward dual antiplatelet therapy over thrombolysis for minor nondisabling stroke, and updated blood pressure management recommendations in acute ischemic stroke. These changes are highly relevant for hospitalists, emergency physicians, neurologists, and internal medicine residents preparing for ABIM and ITE exams. We also examine new data challenging long-standing slow correction thresholds in severe hyponatremia. Observational findings suggest that medium or faster sodium correction may be associated with lower mortality and fewer neurologic complications compared with very slow correction, prompting reexamination of current guideline targets. In oncology and cardiometabolic medicine, we review: • Lung cancer screening data showing 64.9 percent of patients did not meet USPSTF criteria at diagnosis • An age-based low-dose CT screening model that could prevent more than 25,000 deaths annually • GLP-1 receptor agonists associated with a 54 percent reduction in mortality among colon cancer patients with obesity • Survivorship data revealing substantial risk of non-lung secondary malignancies after curative treatment for non-small cell lung cancer We also discuss projected U.S. obesity prevalence reaching nearly 47 percent by 2035, with major implications for diabetes, cardiovascular disease, chronic kidney disease, and health system demand. In gastroenterology, real-world multicenter data demonstrate durable clinical, endoscopic, and histologic remission with upadacitinib in ulcerative colitis at one year. In neurology and environmental health, long-term air pollution exposure is linked to increased risk of motor neuron disease, including ALS, as well as faster functional decline and higher mortality. Additional updates include heavy lifetime alcohol use and colorectal cancer risk from PLCO trial data, and sex-specific response to varenicline in cannabis use disorder, where benefit was observed in men but not women. We also introduce a new recurring segment, Before You Order That Test, inspired by Choosing Wisely principles and focused on high-value care. This episode highlights a critical reminder: do not diagnose or manage asthma without spirometry. This podcast is designed for internal medicine residents, fellows, hospitalists, and attending physicians who want concise, clinically relevant updates across stroke, oncology, cardiometabolic disease, gastroenterology, preventive medicine, and public health. Be relentless. Save lives.

28. feb. 2026 - 13 min
episode Edition 7: TAVR, IV vs IO, ERCP risk plateaus, dementia and cannabis. cover

Edition 7: TAVR, IV vs IO, ERCP risk plateaus, dementia and cannabis.

From FIT screening outpacing colonoscopy in participation to anti-CD20 drugs showing lasting MS control at 7+ years, this edition brings clarity to complex clinical choices. We examine how metabolic syndrome increases young-onset dementia risk by 24%, why post-ERCP pancreatitis rates haven’t budged in two decades, and the unchanged survival edge between IO and IV access in cardiac arrest. As phthalates in plastics are linked to 350,000 heart deaths and cannabis use raises dementia odds, we separate correlation from causation. Meanwhile, fecal therapy via colonoscopy proves safe and 95% effective for recurrent C. diff, and FDA expands TAVR for asymptomatic aortic stenosis with a 50% lower risk of death, stroke, or hospitalization.

26. maj 2025 - 18 min
Tilmeld dig for at lytte
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
Rigtig god tjeneste med gode eksklusive podcasts og derudover et kæmpe udvalg af podcasts og lydbøger. Kan varmt anbefales, om ikke andet så udelukkende pga Dårligdommerne, Klovn podcast, Hakkedrengene og Han duo 😁 👍
Podimo er blevet uundværlig! Til lange bilture, hverdagen, rengøringen og i det hele taget, når man trænger til lidt adspredelse.

Vælg dit abonnement

Mest populære

Begrænset tilbud

Premium

20 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

2 måneder kun 19 kr.
Derefter 99 kr. / måned

Kom i gang

Premium Plus

100 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

Prøv gratis i 7 dage
Derefter 129 kr. / måned

Prøv gratis

Kun på Podimo

Populære lydbøger

Ofte stillede spørgsmål

Flere spørgsmål og svar
Kom i gang

2 måneder kun 19 kr. Derefter 99 kr. / måned. Opsig når som helst.